Status:
COMPLETED
Development of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death Rates
Lead Sponsor:
Mayo Clinic
Conditions:
Endometrial Carcinoma
Eligibility:
FEMALE
40+ years
Phase:
PHASE1
Brief Summary
This phase I trial investigates the development of a new early detection test to reduce racial disparities in endometrial cancer death rates. DNA samples collected from a tampon may be able to be used...
Detailed Description
PRIMARY OBJECTIVES: I. To conduct focus groups to elicit perceptions and knowledge among African American women (AAW) and white women (WW) concerning abnormal uterine bleeding (AUB)/post-menopausal b...
Eligibility Criteria
Inclusion
- AIM 1: Self-identified white women (WW) or African American women (AAW) (will record Hispanic ethnicity)
- AIM 2: Self-reported history of abnormal uterine bleeding (AUB) or post-menopausal bleeding (PMB)
Exclusion
- AIM 1: Women who do not identify as WW or AAW
- AIM 1: Women who are unable to speak and read English
- AIM 2: Prior hysterectomy
- AIM 2: Prior pelvic radiation or are unwilling to comply with instructions
- AIM 2: Pregnant women
Key Trial Info
Start Date :
February 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 25 2023
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT04474184
Start Date
February 1 2020
End Date
January 25 2023
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224-9980